ASCO GU24 special: Assoc. Prof. Barata discusses the results of KEYNOTE-564 and CheckMate-914
EAU Podcasts4 Helmi 2024

ASCO GU24 special: Assoc. Prof. Barata discusses the results of KEYNOTE-564 and CheckMate-914

In this podcast, UROONCO RCC chief editor Dr. Carmen Mir (ES) interviews Assoc. Prof. Pedro Barata from University Hospitals Seidman Cancer Center, USA, about the results of two adjuvant RCC studies: KEYNOTE-564; and CheckMate-914. Assoc. Prof. Barata explains the positive trial results of KEYNOTE-564, which is the first time there has been an overall survival advantage with a PD-1 inhibitor in the pure adjuvant setting in RCC. These results support adjuvant pembrolizumab as a standard of car...

Jaksot(211)

Suosittua kategoriassa Koulutus

rss-murhan-anatomia
voi-hyvin-meditaatiot-2
psykopodiaa-podcast
rss-narsisti
adhd-podi
rss-liian-kuuma-peruna
rss-rahamania
rss-duodecim-lehti
rss-psykalab
rss-tietoinen-yhteys-podcast-2
rss-niinku-asia-on
kesken
psykologia
rss-valo-minussa-2
rss-vapaudu-voimaasi
puhutaan-koiraa
filocast-filosofian-perusteet
rss-rentotapaus
rss-lasnaolon-hetkia-mindfulness-tutuksi
rahapuhetta